Neopep 150 mg (Tablet)
Unit Price: ৳ 2.00 (100's pack: ৳ 200.00)
Medicine Details
| Category | Details |
|---|---|
| Generic | Ranitidine hydrochloride |
| Company | Central pharmaceuticals ltd |
Product Title
- Neopep
- Ranitidine Tablet & Syrup
Categories
- Medicine
- Gastrointestinal Health
Description
- Ranitidine competitively blocks histamine at H2-receptors of the gastric parietal cells which inhibits gastric acid secretion. It does not affect pepsin secretion, pentagastrin-stimulated intrinsic factor secretion or serum gastrin.
Indications
- Treatment of active duodenal ulcer
- Benign gastric ulcer
- Ulcer associated with non-steroidal anti-inflammatory agent
- Post operative stress ulcer
- Zollinger-Ellison Syndrome
- Gastroesophageal reflux disease (GERD)
- Gastro-intestinal haemorrhage from stress ulcer in seriously ill patient
- Recurrent haemorrhage in patients with bleeding peptic ulcer
- Before general anesthesia in patient considered to be at risk of acid aspiration
- Treatment and prevention of ulcer
Pharmacology
- Ranitidine competitively blocks histamine at H2-receptors
Dosage & Administration
- 150 mg tablet
- 300 mg tablet
- 150 mg oral dose
- 300 mg oral dose
- 150 mg IV injection
- 300 mg at bedtime
- 6 g daily dosage
- Oral dose for peptic ulcer in children
- Intravenous injection dosage for children
Interaction
- Delayed absorption and increased peak serum concentration with propantheline bromide
- Minimally inhibits hepatic metabolism of certain drugs
- Alter absorption of pH-dependent drugs
- Reduce bioavailability with antacids
Contraindications
- Patients hypersensitive to Ranitidine
Side Effects
- Altered bowel habit
- Dizziness
- Rash
- Tiredness
- Reversible confusional states
- Headache
- Decreased blood counts
- Muscle or joint pain
Pregnancy & Lactation
- Ranitidine crosses the placenta
- Excreted in human breast milk
- Caution during nursing
Precautions & Warnings
- Reduced dosage for patients with impaired renal and hepatic function
Use in Special Populations
- Use in elderly patients
Overdose Effects
- No particular problems expected following overdosage
Therapeutic Class
- H2 receptor antagonist
Reconstitution
- Slow IV injection preparation
- Intermittent slow IV infusion preparation
- Continuous IV infusion preparation
- Dilution for Zollinger-Ellison syndrome or other hypersecretory conditions
Storage Conditions
- Store in a cool and dry place
- Protect from light